Company news

Immuneoncia Therapeutics Inc. (KRX:424870) news

Immuneoncia Therapeutics Inc. news releases on 6ix. Latest, Jun 2, 2025: ImmuneOncia Announces Interim Results from Phase 1b Clinical Trial of Next-Generation…

View Immuneoncia Therapeutics Inc. →